tiprankstipranks
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market
XVIPF
Xvivo Perfusion AB
RESEARCH TOOLSreports

Xvivo Perfusion AB (XVIPF) Stock Forecast & Price Target

10 Followers
See the Price Targets and Ratings of:

XVIPF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Xvivo
Perfusion AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XVIPF Stock 12 Month Forecast

There Are No Analyst Ratings for XVIPF In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

XVIPF Financial Forecast

XVIPF Earnings Forecast

Next quarter’s earnings estimate for XVIPF is $0.10 with a range of $0.08 to $0.14. The previous quarter’s EPS was $0.11. XVIPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.
Next quarter’s earnings estimate for XVIPF is $0.10 with a range of $0.08 to $0.14. The previous quarter’s EPS was $0.11. XVIPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.

XVIPF Sales Forecast

Next quarter’s sales forecast for XVIPF is $25.30M with a range of $24.24M to $27.16M. The previous quarter’s sales results were $24.26M. XVIPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.
Next quarter’s sales forecast for XVIPF is $25.30M with a range of $24.24M to $27.16M. The previous quarter’s sales results were $24.26M. XVIPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Anthropic Analyst forecast on XVIPF
Anthropic - Opus-4.6
TipRanks - Anthropic
TipRanks - Anthropic
$23.7→$26.92
Hold
34.54%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on XVIPF
DeepSeek - V3.2-Speciale
TipRanks - DeepSeek
TipRanks - DeepSeek
$25.1→$27.78
Hold
38.83%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on XVIPF
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
$25.85→$28.32
Hold
41.51%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on XVIPF
OpenAI - 5.2
TipRanks - OpenAI
TipRanks - OpenAI
$24.46→$27.67
Hold
38.29%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on XVIPF
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
$24.67→$29.17
Buy
45.80%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on XVIPF
Gemini - 3-pro
TipRanks - Google
TipRanks - Google
$25.63→$28.75
Hold
43.66%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Anthropic Analyst forecast on XVIPF
Anthropic - Opus-4.6
TipRanks - Anthropic
TipRanks - Anthropic
$23.7→$26.92
Hold
34.54%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on XVIPF
DeepSeek - V3.2-Speciale
TipRanks - DeepSeek
TipRanks - DeepSeek
$25.1→$27.78
Hold
38.83%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on XVIPF
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
$25.85→$28.32
Hold
41.51%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on XVIPF
OpenAI - 5.2
TipRanks - OpenAI
TipRanks - OpenAI
$24.46→$27.67
Hold
38.29%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on XVIPF
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
$24.67→$29.17
Buy
45.80%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on XVIPF
Gemini - 3-pro
TipRanks - Google
TipRanks - Google
$25.63→$28.75
Hold
43.66%
Upside
Reiterated
04/02/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xvivo Perfusion AB

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+5.70%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.70% per trade.
1 Year
PerPlexity Medical - DevicesTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+5.70%
Copying PerPlexity Medical - Devices's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.70% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+5.70%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XVIPF Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
1
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
0
0
0
0
In the current month, XVIPF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XVIPF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

XVIPF Stock Forecast FAQ

What is XVIPF’s average 12-month price target, according to analysts?
Currently, no data Available
What is XVIPF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for XVIPF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is XVIPF a Buy, Sell or Hold?
      Currently, no data Available
      What is Xvivo Perfusion AB’s price target?
      Currently, no data Available
      What do analysts say about Xvivo Perfusion AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of XVIPF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.